Deerfield Healthcare Innovations Fund, L.P.'s Net Worth

Estimate Recalculated Nov 7, 2024 04:45PM EST

Who is Deerfield Healthcare Innovations Fund, L.P.

Deerfield Healthcare Innovations Fund, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., GRAYBUG VISION, INC., Larimar Therapeutics, Inc., Homology Medicines, Inc., and Oncorus, Inc..

SEC CIK

Deerfield Healthcare Innovations Fund, L.P.'s CIK is 0001646981

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Editas Medicine, Inc.

Investor

Updated Feb 08, 2016

View Quote Details


Form 4	5.85%	100.00K	$16.00	—	Feb 08, 2016	1.81M	Purchase	—	Feb 08
Form 3	—	—	—	—	Feb 02, 2016	—	—	—	—

Showing 2 results

Nuvalent, Inc.

Investor

Updated Oct 24, 2024

View Quote Details


Form 4	-10.34%	-2.00M	$97.75	-$195.50M	Oct 24, 2024	17.99M	Sale	—	Oct 22
Form 4	—	650.00K	$33.50	$21.78M	Nov 07, 2022	19.99M	Purchase	—	Nov 03
Form 4	-80.59%	-102.90M	$17.00	—	Aug 04, 2021	24.78M	Buy-Options	—	Aug 02
Form 3	—	—	—	—	Jul 28, 2021	557.40K	—	—	—

Showing 4 results

Mirum Pharmaceuticals, Inc.

Investor

Updated Jun 08, 2022

View Quote Details


Form 4	-1.17%	-38.48K	$25.01	-$962.26K	Jun 08, 2022	3.24M	Sale	—	Jun 06
Form 4	-100.00%	-99.33K	$15.81	-$1.57M	Jul 13, 2021	3.28M	Sale	—	Jul 09
Form 4	-40.17%	-66.67K	$16.29	-$1.09M	Jul 07, 2021	3.38M	Sale	—	Jul 02 - Jul 07
Form 4	-86.17%	-21.49M	$15.00	$2.49M	Jul 24, 2019	3.45M	Buy-Options	—	Jul 22
Form 3	—	—	—	—	Jul 17, 2019	—	—	—	—

Showing 5 results

GRAYBUG VISION, INC.

Investor

Updated Oct 01, 2020

View Quote Details


Form 4	-84.23%	-28.21M	$16.00	—	Oct 01, 2020	5.28M	Buy-Options	—	Sep 29
Form 3	—	—	—	—	Sep 24, 2020	—	—	—	—

Showing 2 results

Larimar Therapeutics, Inc.

Investor

Updated Feb 16, 2024

View Quote Details


Form 4	35.11%	4.29M	$8.74	$37.50M	Feb 16, 2024	21.23M	Purchase	—	Feb 16
Form 4	190.58%	11.11M	$3.15	$35.00M	Sep 20, 2022	16.94M	Purchase	—	Sep 16
Form 4	13.33%	685.71K	$8.75	$6.00M	Jul 02, 2021	5.83M	Purchase	—	Jun 30
Form 3	—	—	—	—	Jun 08, 2020	6.09M	—	—	—

Showing 4 results

Homology Medicines, Inc.

Investor

Updated Jan 31, 2020

View Quote Details


Form 4	-100.00%	-518.83K	$15.45	-$8.02M	Jan 31, 2020	4.09M	Sale	—	Jan 29 - Jan 30
Form 4	-55.21%	-639.51K	$15.69	-$10.04M	Jan 28, 2020	4.61M	Sale	—	Jan 24 - Jan 28
Form 4	-7.89%	-350.00K	$21.95	-$7.68M	Dec 27, 2019	5.25M	Sale	—	Dec 24
Form 4	-3.58%	-164.73K	$21.78	-$3.59M	Dec 23, 2019	5.60M	Sale	—	Dec 19 - Dec 23
Form 4	85.33%	533.33K	$22.50	$12.00M	Apr 15, 2019	5.76M	Purchase	—	Apr 12
Form 4	-75.03%	-15.70M	$16.00	$10.00M	Apr 04, 2018	5.23M	Buy-Options	—	Apr 02
Form 3	—	—	—	—	Mar 27, 2018	—	—	—	—

Showing 7 results

Oncorus, Inc.

Investor

Updated Dec 30, 2022

View Quote Details


Form 4	-11.46%	-336.24K	$0.26	-$88.25K	Dec 30, 2022	2.60M	Sale	—	Dec 28 - Dec 30
Form 4	-2.44%	-73.38K	$0.27	-$19.90K	Dec 27, 2022	2.93M	Sale	—	Dec 22 - Dec 27
Form 4	-4.09%	-128.26K	$0.29	-$37.63K	Dec 21, 2022	3.01M	Sale	—	Dec 19 - Dec 21
Form 4	-0.44%	-13.79K	$0.39	-$5.33K	Dec 15, 2022	3.14M	Sale	—	Dec 13 - Dec 15
Form 4	10.53%	300.00K	$19.00	$5.70M	Feb 18, 2021	3.15M	Purchase	—	Feb 17
Form 4	-87.25%	-19.50M	$15.00	—	Oct 08, 2020	2.85M	Buy-Options	—	Oct 06
Form 3	—	—	—	—	Oct 01, 2020	—	—	—	—

Showing 7 results